ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Isolyte P W/ Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?
Isolyte P W/ Dextrose 5% In Plastic Container is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of New Mexico | Phase 2 |
See all ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | ISOLYTE P W/ DEXTROSE 5% IN PLASTIC CONTAINER | dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium acetate | INJECTABLE;INJECTION | 019025-001 | Dec 27, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
